4
Changes in Ownership
Syndax Pharmaceuticals Inc Filed Acc 0001562180-19-002012
SVP, Chief Medical Officer bought 1,104 shares at an average $4.92 ($5,436)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Meyers Michael L. SVP, Chief Medical Officer | 2019-03-21 | Purchase | +1,000 | $4.93 | $4,930 | 7,118 | D |
| Meyers Michael L. SVP, Chief Medical Officer | 2019-03-21 | Purchase | +104 | $4.87 | $506 | 7,222 | D |
| Open-market purchases · 1,104 sh · avg $4.92 · $5,436 | |||||||
Loading xslF345X03/primarydocument.xml…